In the Original Investigation titled, “Assessment of the Safety of Glucocorticoid Regimens in Combination With Abiraterone Acetate,” which published online June 27, 2019, in JAMA Oncology,1 there was an error in the title. The correct title is “Assessment of the Safety of Glucocorticoid Regimens in Combination With Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer.” This article was corrected online.
Reference
- 1.Attard G, Merseburger AS, Wiebke A, et al. . Assessment of the safety of glucocorticoid regimens in combination with abiraterone acetate for metastatic castration-resistant prostate cancer [published online June 27, 2019]. JAMA Oncol. doi: 10.1001/jamaoncol.2019.1011 [DOI] [PMC free article] [PubMed] [Google Scholar]